Skip to content
Skip to navigation menu

 

Welcome

Welcome to the Welsh School of Pharmacy.

The Welsh School of Pharmacy is one of twenty six UK schools of pharmacy and the only one in Wales. For nearly a century, the School has cultivated a strong tradition of innovative pharmaceutical education, scientific research and service to the pharmacy profession, especially in Wales.

About the School
Research at the School of Pharmacy

Location

The school is located in the Redwood Building named after Theophilus Redwood the first Professor of Pharmacy in Britain.

More information
Contact details

The Welsh School of Pharmacy celebrates its 90th anniversary in 2009
Students working in a Pharmacy.

Undergraduate

We offer one undergraduate degree programme, the Masters in Pharmacy (MPharm), which is fully approved by the Royal Pharmaceutical Society of Great Britain as a recognised route of entry in the profession of pharmacy.

Prospective Undergraduate Students information
Current Students

Details for Undergraduate Enrolment Week


 

Pharmacists using laptop

Postgraduate

We offer a range of taught postgraduate courses, as well as opportunities for supervised research study leading to Master or Doctoral degrees.

Taught Postgraduate Courses

Postgraduate Research study
Postgraduate Research Studentships Available

Welsh Centre for Pharmacy Professional Education
WCPPE Logo
PhD students Monerah Al Soraj and Catherine Watkins together with ATJ analysing drug delivery systems in leukaemia cells using the new confocal microscopy facility at WSOP.

Research

Research in the Welsh School of Pharmacy in Cardiff has been organised around five research groups 

 

 

Recently Initiated Research Projects

Highlight Publications

Cinnamaldehydes inhibit thioredoxin reductase and induce Nrf2: potential candidates for cancer therapy and chemoprevention.

Chew E-H, Nagle AA, Zhang Y, Scarmagnani S, Palaniappan P, Bradshaw TD, Holmgren A, Westwell AD 

Free Rad. Biol. Med. (2010), 48, 98-111.

The discovery of natural product-derived antitumour cinnamaldehydes with either chemopreventative or chemotherapeutic properties dependent on dose.

Natural Exposure to Cutaneous Anthrax Gives Long-Lasting T Cell Immunity Encompassing Infection-Specific Epitopes.

Rebecca J. Ingram, Gökhan Metan, Bernard Maillere, Mehmet Doganay, Yusuf Ozkul, Louise U. Kim, Les Baillie , Hugh Dyson, E. Diane Williamson, Karen K. Chu, Stephanie Ascough, Steven Moore, Theresa B. Huwar, John H. Robinson, Shiranee Sriskandan, and Daniel M. Altmann

J Immunol. published online March 5, 2010, doi:10.4049/jimmunol.0901581

...

A Large Conductance (BK) Potassium Channel subtype affects both growth and mineralisation of Human Osteoblasts.

Henney N, Li B, Elford C, Reviriego P, Campbell A, Wann K , Evans B.

Am J Physiol Cell Physiol (2009)

The 1st paper to describe the pharmacological profile of a subtype of K channel (BK channel) in osteobasts (bone cells) and to implicate one subtype of the BK channel in cell growth and the mineralisation process.

Low concentration thresholds of plasma membranes for rapid energy- independent translocation of a cell penetrating peptide.

Watkins C, Schmaljohann, D., Futaki, S., and Jones, A.T.

Biochem J. (2009) 420 (2) 179-189

This highlights the high porosity of plasma membranes to cationic cell penetrating peptides, thus opening new avenues for their use as vectors for bio-active entities.

Elevated Src kinase activity attenuates tamoxifen response in vitro and is associated with poor prognosis clinically.

Morgan L, Gee J, Pumford S, Farrow L, Finlay P, Robertson J, Ellis I, Kawakatsu H, Nicholson RI and Hiscox S

Cancer Biology and Therapy (2009) 8(16):23-31

A translational study that supports our previous in vitro observations suggesting that Src kinase is an important determinant of the therapeutic response of breast cancers